Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed
- PMID: 10574836
- PMCID: PMC1117123
- DOI: 10.1136/bmj.319.7222.1385
Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed
Comment in
-
More trials on early treatment with corticosteroids are needed.BMJ. 2000 Apr 1;320(7239):941. BMJ. 2000. PMID: 10742018 Free PMC article. Clinical Trial. No abstract available.
References
-
- Silverman WA. Retrolental fibroplasia: a modern parable. New York: Grune and Stratton; 1980.
-
- Johnson A. Randomised controlled trials in perinatal medicine: 3. Identifying and measuring endpoints in randomised controlled trials. Br J Obstet Gynaecol. 1997;104:768–771. - PubMed
-
- Halliday HL. Clinical trials of postnatal corticosteroids: inhaled and systemic. Biol Neonate. 1999;76 (suppl 1):29–40. http://BioMedNet.com/karger .( http://BioMedNet.com/karger) ) - PubMed
-
- Halliday HL, Ehrenkranz RA Cochrane Collaboration, editors. Cochrane Library. Issue 4. Oxford: Update Software; 1999. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
-
- Halliday HL, Ehrenkranz RA Cochrane Collaboration, editors. Cochrane Library. Issue 4. Oxford: Update software; 1999. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical